Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant

Cytotherapy ◽  
2014 ◽  
Vol 16 (4) ◽  
pp. S7
Author(s):  
A. Papadopoulou ◽  
U.L. Katari ◽  
U. Gerdemann ◽  
I. Tzannou ◽  
C. Martinez ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document